Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid GlobeNewswire Nawigacja wpisu New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy – AdventHealth India may soon have Braille labelling on medicines – Mint
